ProQR Therapeutics
PRQR
PRQR
51 hedge funds and large institutions have $299M invested in ProQR Therapeutics in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
13% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 15
5.34% more ownership
Funds ownership: 55.73% → 61.07% (+5.3%)
2% more funds holding
Funds holding: 50 → 51 (+1)
Holders
51
Holding in Top 10
2
Calls
$22K
Puts
$15K
Top Buyers
| 1 | +$47.5M | |
| 2 | +$10.8M | |
| 3 | +$10.7M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$8.45M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$8.28M |
Top Sellers
| 1 | -$3.3M | |
| 2 | -$1.44M | |
| 3 | -$1.11M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.09M |
| 5 |
AA
ALPS Advisors
Denver,
Colorado
|
-$446K |